logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7371753 B1

PDFFull Text
Date of Patent:
May. 13, 2008

Filed:

Aug. 25, 2005

Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions

Applicants:

Heinz Stadtmueller, Gaweinstal, AT;

Harald Engelhardt, Ebreichsdorf, AT;

Andreas Schoop, Vienna, AT;

Martin Steegmaier, Vienna, AT;

Matthias Hoffmann, Mittelbiberach, DE;

Matthias Grauert, Biberach, DE;

Inventors:

Heinz Stadtmueller, Gaweinstal, AT;

Harald Engelhardt, Ebreichsdorf, AT;

Andreas Schoop, Vienna, AT;

Martin Steegmaier, Vienna, AT;

Matthias Hoffmann, Mittelbiberach, DE;

Matthias Grauert, Biberach, DE;

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim, DE;

Attorneys:

Michael Morris

Mary-Ellen M. Devlin

Anthony P. Bottino

Primary Examiner:

Cecilia M Jaisle

Int. Cl.
CPC ...
A61K 31/5025 (2006.01); A61K 31/496 (2006.01); A61K 31/551 (2006.01); A61K 31/5355 (2006.01); C07D 237/20 (2006.01); C07D 237/22 (2006.01); C07D 239/10 (2006.01); C07D 241/18 (2006.01); C07D 243/08 (2006.01); C07D 413/12 (2006.01); A61P 35/00 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 211/74 (2006.01); C07D 211/72 (2006.01); C07D 211/84 (2006.01); C07D 211/86 (2006.01); C07D 213/73 (2006.01); C07D 213/76 (2006.01); C07D 213/22 (2006.01);
U.S. Cl.
CPC ...
Abstract

Disclosed are new dihydropteridinones of general formula (I) wherein the groups Rto R, Rto R, W, Qand Qhave the meanings given in the claims and specification, the isomers thereof and the use thereof for preparing a pharmaceutical composition for the treatment of diseases characterised by excessive or abnormal cell proliferation.

Find Patent Forward Citations

Loading…